These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16249369

  • 1. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG, Wiehler WB, Pannirselvam M, Jiang Y, Berger JP, Severson D, Anderson TJ, Triggle CR.
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [Abstract] [Full Text] [Related]

  • 2. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
    Carley AN, Semeniuk LM, Shimoni Y, Aasum E, Larsen TS, Berger JP, Severson DL.
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
    [Abstract] [Full Text] [Related]

  • 3. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thulé PM, Sutliff RL, Hart CM.
    Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
    [Abstract] [Full Text] [Related]

  • 4. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
    Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
    [Abstract] [Full Text] [Related]

  • 5. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U.
    Circulation; 2007 Jul 10; 116(2):163-73. PubMed ID: 17592079
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.
    Belmadani S, Palen DI, Gonzalez-Villalobos RA, Boulares HA, Matrougui K.
    Diabetes; 2008 Jun 10; 57(6):1629-37. PubMed ID: 18319304
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms underlying the chronic pravastatin treatment-induced improvement in the impaired endothelium-dependent aortic relaxation seen in streptozotocin-induced diabetic rats.
    Kobayashi T, Matsumoto T, Kamata K.
    Br J Pharmacol; 2000 Sep 10; 131(2):231-8. PubMed ID: 10991915
    [Abstract] [Full Text] [Related]

  • 17. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK, Chae YN, Son MH, Kim SH, Kim JK, Moon HS, Park CS, Bae MH, Kim E, Han T, Choi HH, Shin YA, Ahn BN, Lee CH, Lim JI, Shin CY.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):119-25. PubMed ID: 18727927
    [Abstract] [Full Text] [Related]

  • 18. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 24; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.
    Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewari-Singh N, Capobianco S, Chilian WM, Zhang C.
    Circulation; 2007 Jan 16; 115(2):245-54. PubMed ID: 17200442
    [Abstract] [Full Text] [Related]

  • 20. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species.
    Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT.
    Am J Physiol Endocrinol Metab; 2007 Nov 16; 293(5):E1311-9. PubMed ID: 17711985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.